Prevention of transfusion-transmitted cytomegalovirus infection after allogeneic HCT: the debate continues

Biol Blood Marrow Transplant. 2013 Dec;19(12):1659-60. doi: 10.1016/j.bbmt.2013.10.007. Epub 2013 Oct 14.

Author

Margaret L Green¹

Affiliation

¹ Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle, Washington. Electronic address: [email protected].

PMID: 24135372
DOI: 10.1016/j.bbmt.2013.10.007

No abstract available

Publication types

Comment

MeSH terms

Cytomegalovirus / isolation & purification*
Cytomegalovirus Infections / blood*
Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Male
Viremia / diagnosis*

Grants and funding

K23 AI097234/AI/NIAID NIH HHS/United States